Supporting UCLA and partner faculty in advancing collaborative global health research 

The Global Health Seed Grant was established in 2019 with support from the Dean's Office and UCLA Health International Services. The program supports UCLA faculty and their global partners in advancing collaborative global health research.

The Seed Grant aims to (1) support multidisciplinary global health research that addresses health priorities relevant to partner communities, (2) establish and strengthen long-term research partnerships between UCLA and global partner institutions, and (3) support the development and mentorship of early-career investigators at UCLA and global partner sites.

List of projects awarded from 2019 through 2027:

  • 2020/2021
    • A study of an adapted approach to HIV-exposed infant follow-up using fever as a criterion for testing to improve timely diagnosis and antiretroviral therapy in Mozambique
    • Adapt the TransAction intervention for trans women with/at risk of HIV in Vietnam
  • 2021/2022
    • The use of long-term preserved corneas for perforated corneal ulcer in Vietnam
    • A new algorithm to detect critical congenital heart disease at different altitudes in Peru
    • Mixed-methods study to collect data about what affects adherence and engagement in care among hypertensive adults in Thailand
  • 2022/2023
    • Feasibility of antenatal syphilis and HIV point of care testing to prevent mother-to-child transmission in Uganda
  • 2023/2024
    • Psychiatric comorbidity and recovery outcomes among STAR-OM patients in Vietnam
    • Optimization of mHealth follow-up in Cameroon: A multi-methods approach
  • 2024/2025
    • Pulmonary and economic outcomes of treated tuberculosis in a TB-endemic population in Peru
    • Forest conservation & human health at the intersection of community based participatory research & ethnography in Togo
    • Development of a clinical decision support tool to address the epilepsy treatment gap in Uganda: A pilot study
  • 2025/2026
    • Optimizing maternal outcomes: Adapting quantitative blood loss measurement in routine maternity care in India
    • Assessment of pathology personnel and institutional resources in Africa
    • South African college student sexual, reproductive, and mental health promotion, and violence prevention - Sex, Cookies & Relationships (SAC-SCR)
    • Implementation of a fetal cardiac screening program to improve early detection of congenital heart disease in Mwanza, Tanzania*
  • 2026/2027

    • ACT PrEP pilot: Integrating aetiological STI testing (point-of-care), cognitive behavioural counselling, and targeted partner engagement to support PrEP enrollment and persistence in pregnant and postpartum women in South Africa
    • Locating rural communities for targeted yellow fever prevention in Ghana via remote sensing
    • Impact of virtual reality on perioperative anxiety reduction in children in resource-variable settings
    • Building critical care capacity at Partners In Hope, Malawi: A simulation-based BLS/ACLS implementation and competency study

    *Note: The Tanzania project represents the first year of the $15,000 award category.

For the 2027-2028 cycle, awards are available at two funding levels: up to $15,000 or up to $50,000 for a one-year project period. Applicants may apply for only one funding level.

Eligibility
  • Principal Investigator (PI): Must be a UCLA faculty member. Adjunct faculty, fellows, and residents are not eligible to serve as PI, but may participate as co-investigators or Early Career Investigators.
  • DGSOM Affiliation: At least one investigator on the team must hold a faculty appointment within the David Geffen School of Medicine (DGSOM).
  • Team Composition: Projects must include a multidisciplinary team representing either:
    • At least two distinct scientific disciplines (e.g., clinical science and social science), or
    • At least two distinct clinical specialties (e.g., internal medicine and surgery).
  • Cross-school collaboration within UCLA is strongly encouraged, particularly across two or more UCLA schools.
  • Global Partnership: A Primary Global Partner Site Investigator must be included as a co-investigator on the research team.
  • Research conducted in low-income and lower-middle-income countries will be prioritized for funding.
  • Research in upper-middle-income or high-income countries is unlikely to be funded and will require a clear and compelling justification.
  • Projects in upper-middle-income or high-income countries must specifically address the needs of an underserved or resource-limited population within that country.
  • Early Career Investigators:
    • Each project must include:
      • At least one Early Career Investigator from UCLA, and
      • At least one Early Career Investigator from the global partner site.
    • The UCLA Early Career Investigator must be different from the UCLA PI.
    • The Global Site Early Career Investigator must be different from the Primary Global Partner Site Investigator.
    • The full proposal must include a mentorship and capacity-building plan describing how the project will support the development of both Early Career Investigators and how their progress will be evaluated.
  • IRB and Regulatory Approvals: IRB approval is not required at the time of application. For funded projects, all required UCLA and global partner site IRB and/or regulatory approvals must be obtained before funds are released. 
  • Funding Restrictions: Training exchanges as stand-alone projects are not supported. Training may be included when it is part of a broader research and capacity-building effort involving Early Career Investigators.
  • For projects involving laboratory science, the majority of laboratory work must take place at the global partner site. Projects in which the majority of laboratory work will occur at UCLA or in Los Angeles-based laboratories are not eligible.
  • PIs may not receive Seed Grant funding in two consecutive cycles for projects involving the same global partner site. A PI funded in the previous cycle may apply with a new global partner site. 

     

For complete requirements, please review the 2027-2028 Request for Applications.

Application Requirements

Letter of Intent (LOI)

Submit Letter of Intent

Applicants must submit an LOI via Qualtrics that includes:nvestigative Team: UCLA PI, Primary Global Partner Site Investigator, additional co-investigators (if applicable), and designated Early Career Investigators from UCLA and the global partner site

  • Scientific Disciplines: Two primary scientific disciplines or clinical specialties represented in the proposed research
  • Global Partner Site: Partner institution, location, and brief description of its role in the proposed research
  • Proposed Project: Tentative project title, brief project summary, and one to three specific research aims, including objectives and anticipated outcomes
  • Laboratory Activities, if applicable: Brief description of proposed laboratory activities and confirmation that the majority of laboratory work will take place at the global partner site
  • Funding Level Requested: Up to $15,000 or up to $50,000

For projects proposed in upper-middle-income or high-income countries, the LOI must specifically address the needs of an underserved or resource-limited population within that country.

Full Proposal (By Invitation Only)

Invited applicants must submit:

  1. Cover Page and Table of Contents/Checklist using the provided template.
  2. Research Proposal, maximum four pages, 11-point Arial font with 0.5-inch margins, including:
    • Specific Aims
    • Significance
    • Approach/Methodology
    • Global Health Impact
    • Timeline
    • Global partner site, strengths of the partnership, and collaborative work to date
    • Mentorship and capacity-building plans for Early Career Investigators at UCLA and the global partner site
    • Additional justification for upper-middle-income or high-income settings, if applicable
    • Laboratory activities and capacity at the global partner site, if applicable
  3. Biosketches in NIH format for the PI and all co-investigators. A CV may be submitted in lieu of a biosketch for Early Career Investigators.  Application
  4. Itemized Budget and Budget Justification.
  5. Letter of Support from the Primary Global Partner Site Investigator and any other key collaborators, as applicable.
  6. Letter of Support from the UCLA PI's Division Chief or Department Chair confirming that the PI is in good standing and supports the proposed global partnership and research.

2027-28 Application process and timeline

For complete application requirements and program policies, please review the 2027-2028 Request for Applications.

  • Step 1: Submit a Letter of Intent
    Due: Friday, October 16, 2026 – 5:00 PM PST (via Qualtrics)
    All applicants must submit a Letter of Intent before submitting a full proposal.
  • Step 2: Invitation to Submit Full Proposal
    Week of November 23, 2026
    Selected applicants will be notified by email and invited to submit a full proposal.

    Applicants are encouraged to review the Scoring Criteria for Reviewers and FAQs while preparing their application.

  • Step 3: Full Proposal Submission
    Due: January 12, 2027, at 5:00 PM PT
    Resources
  • Step 4: Award Notification
    Early-to-mid April 2027
  • Step 5: Project and Award Spending Periods
    Project Period: May 1, 2027 – June 30, 2028
    Award Spending Period: July 1, 2027 – April 30, 2028
     

    Project activities may begin as early as May 1, 2027 and continue through June 30, 2028. Award funds will be available beginning July 1, 2027, and all award-funded expenses must be incurred by April 30, 2028.

    The remaining project period, through June 30, 2028, allows time for completion of project activities and submission of final reimbursements to the Dean's Office.

    All required UCLA and global partner site IRB and/or regulatory approvals must be obtained before applicable research activities begin and before funds are released, as required.

    No-cost extensions beyond April 30, 2028 will be permitted.

Alert

The terms of this award may be amended should University funding be significantly compromised due to unforeseen circumstances.